SIZE XSSIZE SMSIZE MDSIZE LG

*New* Sponsored Early Career Research Grant

The Sponsored Early Career Research Grant (ECR), supported by Acerta Pharma, a member of the AstraZeneca Group, will provide funding to promising investigators early in their career to encourage and promote quality, basic, and pre-clinical translational lab-based research, although clinical research may also be considered, in hematology/oncology among HOPA members. The purpose of this award is to fund US-based pharmacists within their first 7 years post completion of formal training and have not yet attained R21 level funding. The Acerta Pharma supported ECR Grant will award up to $50,000 to the chosen applicant, paid in two equal installments over a two-year period.

The grant funds will be used to provide an ECR award to individuals whose research has an emphasis on hematology research, primarily within research concerning Chronic Lymphocytic Leukemia (CLL), B‐Cell Malignancies, and Non‐Hodgkin’s lymphomas.

The sponsored ECR Grant will award $50,000 to the chosen applicant, paid in two equal installments over a two-year period.

The request for submission of letters of intent (LOIs) for the 2018 HOPA Early Career Research Grant is now closed.

Learn more about the Sponsored Early Career Research Grant.

Research Fund Award

The Research Fund Award is intended to support a hematology/oncology pharmacy practice research project with subsequent publication that aligns closely with the HOPA strategic plan to demonstrate the value of hematology/ oncology pharmacy practice. Pharmacy practice is broadly defined to include areas of research such as: clinical or patient outcomes, surveys, patient safety, standards validation, and basic/translational science applications. Multiple institutions may be involved in the project, and a project with co-PIs are allowed. A subsequent publication resulting from the research project is expected within a year of the study completion.

A total of $100,000 is available to be awarded to up to three grants through a competitive peer-review process described below. HOPA aims to fund at least one practice-based and one basic/translational study.

The request for submission of letters of intent (LOIs) for the 2018 HOPA Early Career Research Grant has closed.

Learn more about the Research Fund Award.

Early Career Research Grant

The HOPA Early Career Research Grant (ECR) will provide funding to promising investigators early in their career to encourage and promote quality basic and pre-clinical translational lab-based research in oncology among HOPA members. The purpose of this award is to fund United States based pharmacists within the first 7 years post completion of formal training who have not yet attained R21 level funding. Mentoring will be an essential component of the ECR Grant. Awarded early career pharmacists will be required to work with a mentor either from their sponsoring institution or to find a mentor from another institution within the United States.

The HOPA ECR Grant will award $50,000 to the chosen applicant, paid in two equal installments over a two-year period.

The request for submission of letters of intent (LOIs) for the 2018 HOPA Early Career Research Grant is now closed.

Learn more about the Early Career Research Grant.

xs
sm
md
lg